Showing results (1-10 of 830) with videos related to
Sort By:
Pageof 83
Trends in Cardiovascular Medicine|March 10, 2010
Discovery and validation of new molecular targets in treating dyslipidemia: the role of human geneticsAmit V Khera, Daniel J RaderCurrent Atherosclerosis Reports|April 29, 2010
Future therapeutic directions in reverse cholesterol transportAmit V Khera, Daniel J RaderEuropean Journal of Heart Failure|May 28, 2013
Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathyParin J Patel, Amit V Khera, Robert L Wilensky, et al.The American Journal of Cardiology|November 30, 2014
Effects of niacin, statin, and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 levels in patients with dyslipidemiaAmit V Khera, Arman Qamar, Muredach P Reilly, et al.European Heart Journal|June 27, 2015
Potent peroxisome proliferator-activated receptor-α agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndromeAmit V Khera, John S Millar, Giacomo Ruotolo, et al.The American Journal of Cardiology|August 10, 2010
On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study)Amit V Khera, Megan L Wolfe, Christopher P Cannon, et al.Journal of the American College of Cardiology|November 5, 2011
The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery diseaseParin J Patel, Amit V Khera, Kashif Jafri, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 13, 2015
Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabeticsArman Qamar, Sumeet A Khetarpal, Amit V Khera, et al.The American Journal of Cardiology|June 30, 2015
On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study)Amit V Khera, Arman Qamar, Sabina A Murphy, et al.The American Journal of Cardiology|January 8, 2017
Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective CohortConnor A Emdin, Amit V Khera, Pradeep Natarajan, et al.Pageof 83